1. Biologics in inflammatory disease: infliximab associated risk of lymphoma development. Issue 5 (14th April 2005) Authors: Bucher, C; Degen, L; Dirnhofer, S; Pless, M; Herrmann, R; Schraml, P; Went, P Journal: Gut Issue: Volume 54:Issue 5(2005) Page Start: 732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗